From October 1, 2023 to December 31, 2023, the company has repurchased 512,262 shares, representing 0.69% for $177.02 million. With this, the company has completed the repurchase of 1,265,661 shares, representing 1.71% for $438.34 million under the buyback announced on February 16, 2023.
West Pharmaceutical Services, Inc.
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
317.7 USD | -0.23% | -1.60% | -9.78% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.78% | 23.19B | |
-6.21% | 180B | |
-0.08% | 109B | |
-3.09% | 68.93B | |
-4.84% | 46.41B | |
+12.85% | 45.43B | |
+7.38% | 43.26B | |
+19.71% | 30.05B | |
+16.10% | 25.19B | |
-7.44% | 23.34B |
- Stock Market
- Equities
- WST Stock
- News West Pharmaceutical Services, Inc.
- Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023.